Skip to main content

Narcolepsy Evaluation

CPT

81383(x2)

  • Share
  • Print
  • Updated on 03/17/2025

Test Details

Methodology

Next-generation sequencing or other methods as needed

Result Turnaround Time

3 - 7 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Use

HLA DQB1*06:02 and HLA DQA1*01:02 are associated statistically with narcolepsy and are sometimes used as tests in support of that diagnosis.

Special Instructions

This test currently is not approved for use in New York state.

If you have questions, please call HLA customer service at 800-533-1037 for assistance in selecting the appropriate HLA test for the patient.

Ship the specimen to arrive in the laboratory between Monday and Friday.

If you have questions, please call HLA customer service at 800-533-1037 for assistance in selecting the appropriate HLA test for the patient.

This test currently is not approved for use in New York state.

If you have questions, please call HLA customer service at 800-533-1037 for assistance in selecting the appropriate HLA test for the patient.

Ship the specimen to arrive in the laboratory between Monday and Friday.

Limitations

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Specimen Requirements

Specimen

Whole blood or buccal swabs

Volume

7 mL or four buccal swabs

Minimum Volume

3 mL or four buccal swabs

Container

Lavender-top (EDTA) tube or four buccal swabs in a sealed envelope (buccal swab kit). If submitting buccal swabs, please use the kit provided by Labcorp. To obtain the buccal swab kit or to discuss other specimen types, please call 800-533-1037.

Collection Instructions

Standard phlebotomy procedures or follow buccal swab kit instructions

Storage Instructions

Maintain specimen at room temperature. Protect from extreme heat or cold.

Causes for Rejection

Improper collection tube; mislabeled specimen

References

Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet. 2001 Mar;68(3):686-699. PubMed 11179016

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
167655 Narcolepsy Evaluation 94492-6 167656 DQA1*01:02 53737-3
167655 Narcolepsy Evaluation 94492-6 167657 DQB1*06:02 63558-1
167655 Narcolepsy Evaluation 94492-6 167149 Please Note: 77202-0
167655 Narcolepsy Evaluation 94492-6 167135 HLA NGS Methodology 49549-9
Order Code167655
Order Code NameNarcolepsy Evaluation
Order Loinc94492-6
Result Code167656
Result Code NameDQA1*01:02
UofM
Result LOINC53737-3
Order Code167655
Order Code NameNarcolepsy Evaluation
Order Loinc94492-6
Result Code167657
Result Code NameDQB1*06:02
UofM
Result LOINC63558-1
Order Code167655
Order Code NameNarcolepsy Evaluation
Order Loinc94492-6
Result Code167149
Result Code NamePlease Note:
UofM
Result LOINC77202-0
Order Code167655
Order Code NameNarcolepsy Evaluation
Order Loinc94492-6
Result Code167135
Result Code NameHLA NGS Methodology
UofM
Result LOINC49549-9